Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, et al. Pathogenesis of Multiple Organ Injury in COVID-19 and potential therapeutic strategies. Front Physiol. 2021;12:593223.
Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613–28.
Rossetti CL, Cazarin J, Hecht F, Beltrão FEL, Ferreira ACF, Fortunato RS, et al. COVID-19 and thyroid function: what do we know so far? Front Endocrinol (Lausanne). 2022;13:1041676.
Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, et al. The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal Axis. Endocr Pract. 2021;27(2):83–9.
Tan T, Khoo B, Mills EG, Phylactou M, Patel B, Eng PC, et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8(8):659–60.
Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381–7.
Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2021;31(1):8–11.
Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021;9(1):88–98.
Dhindsa S, Champion C, Deol E, Lui M, Campbell R, Newman J, et al. Association of male hypogonadism with risk of hospitalization for COVID-19. JAMA Netw Open. 2022;5(9):e2229747.
Dhindsa S, Zhang N, McPhaul MJ, Wu Z, Ghoshal AK, Erlich EC, et al. Association of Circulating Sex Hormones with Inflammation and disease severity in patients with COVID-19. JAMA Netw Open. 2021;4(5):e2111398.
Suba Z. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci. 2020;23(1):75–85.
Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. Potential influence of Menstrual Status and Sex hormones on female severe Acute Respiratory Syndrome Coronavirus 2 infection: a cross-sectional Multicenter Study in Wuhan, China. Clin Infect Dis. 2021;72(9):e240–8.
Hadadi A, Pirzadeh M, Kazemian S, Ashraf H, Ebrahimi M, Karbalai Saleh S, et al. COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection. Virol J. 2022;19(1):123.
Huespe I, Carboni Bisso I, Di Stefano S, Terrasa S, Gemelli NA, Las Heras M. COVID-19 Severity Index: a predictive score for hospitalized patients. Med Intensiva (Engl Ed). 2020;46(2):98–101.
Mao Y, Xu B, Guan W, Xu D, Li F, Ren R, et al. The adrenal cortex, an underestimated site of SARS-CoV-2 infection. Front Endocrinol (Lausanne). 2021;11:593179.
Çabuk SA, Cevher AZ, Küçükardalı Y. Thyroid function during and after COVID-19 infection: a review. touchREV Endocrinol. 2022;18(1):58–62.
Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739–41.
Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.
Zou R, Wu C, Zhang S, Wang G, Zhang Q, Yu B, et al. Euthyroid sick syndrome in patients with COVID-19. Front Endocrinol (Lausanne). 2020;11:566439.
Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab. 2021;106(2):e803–11.
Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44(5):1031–40.
Sallas IM, Kolilekas L, Levounets A, Tsoukalas D, Zervas E, Gaga M. Thyroid dysfunction reflects severity of COVID-19 pneumonia in hospitalized patients. Eur Resp J. 2022;60(suppl 66):4074.
Campi I, Bulgarelli I, Dubini A, Perego GB, Tortorici E, Torlasco C, et al. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection. Eur J Endocrinol. 2021;184(5):699–709.
Beltrão FEL, Beltrão DCA, Carvalhal G, Beltrão FEL, Brito ADS, Capistrano KHRD, et al. Thyroid hormone levels during Hospital Admission inform Disease Severity and Mortality in COVID-19 patients. Thyroid. 2021;31(11):1639–49.
Baldelli R, Nicastri E, Petrosillo N, Marchioni L, Gubbiotti A, Sperduti I, et al. Thyroid dysfunction in COVID-19 patients. J Endocrinol Invest. 2021;44(12):2735–9.
Fliers E, Boelen A. An update on non-thyroidal illness syndrome. J Endocrinol Invest. 2021;44(8):1597–607.
Zheng J, Cui Z, Shi N, Tian S, Chen T, Zhong X, et al. Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19. BMC Endocr Disord. 2021;21(1):228.
Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to Immune Profile, Disease Status, and Outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926–35.
Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab. 2008;19(5):175–80.
Van den Berghe G, Boonen E, Walker BR. Reduced cortisol metabolism during critical illness. N Engl J Med. 2013;369(5):481.
Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283(8):1038–45.
Jensterle M, Herman R, Janež A, Mahmeed WA, Al-Rasadi K, Al-Alawi K, et al. The relationship between COVID-19 and hypothalamic-pituitary-adrenal Axis: a large spectrum from Glucocorticoid Insufficiency to excess-the CAPISCO International Expert Panel. Int J Mol Sci. 2022;23(13):7326.
Ahmadi I, Estabraghnia Babaki H, Maleki M, Jarineshin H, Kaffashian MR, Hassaniazad M, et al. Changes in physiological levels of Cortisol and adrenocorticotropic hormone upon hospitalization can predict SARS-CoV-2 mortality: a Cohort Study. Int J Endocrinol. 2022;2022:4280691.
Güven M, Gültekin H. Could serum total cortisol level at admission predict mortality due to coronavirus disease 2019 in the intensive care unit? A prospective study. Sao Paulo Med J. 2021;139(4):398–404.
Das L, Dutta P, Walia R, Mukherjee S, Suri V, Puri GD, et al. Spectrum of Endocrine Dysfunction and Association with Disease Severity in patients with COVID-19: insights from a cross-sectional, observational study. Front Endocrinol (Lausanne). 2021;12:645787.
Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the Endocrine System: a mini-review. Endocrinology. 2022;163(1):bqab203.
Pastores SM, Annane D, Rochwerg B, Corticosteroid Guideline Task Force of SCCM and ESICM. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part II): society of critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2018;44(4):474–7.
Nassau DE, Best JC, Kresch E, Gonzalez DC, Khodamoradi K, Ramasamy R. Impact of the SARS-CoV-2 virus on male reproductive health. BJU Int. 2022;129(2):143–50.
Okwan-Duodu D, Lim EC, You S, Engman DM. TMPRSS2 activity may mediate sex differences in COVID-19 severity. Signal Transduct Target Ther. 2021;6(1):100.
Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37(2):e3377.
Kadihasanoglu M, Aktas S, Yardimci E, Aral H, Kadioglu A. SARS-CoV-2 Pneumonia affects male Reproductive hormone levels: a prospective, Cohort Study. J Sex Med. 2021;18(2):256–64.
Abedi AR, Dashti M, Salehi Mashhadsari SP, Eghbaldoost A, Mehravar R, Ghadirzadeh E, et al. Assessing the relationship between serum testosterone levels and COVID-19 outcomes in admitted patients. Men’s Health J. 2022;6(1):12.
Cinislioglu AE, Cinislioglu N, Demirdogen SO, Sam E, Akkas F, Altay MS, et al. The relationship of serum testosterone levels with the clinical course and prognosis of COVID-19 disease in male patients: a prospective study. Andrology. 2022;10(1):24–33.
Beltrame A, Salguero P, Rossi E, Conesa A, Moro L, Bettini LR, et al. Association between sex hormone levels and clinical outcomes in patients with COVID-19 admitted to Hospital: an Observational, Retrospective, Cohort Study. Front Immunol. 2022;13:834851.
Schroeder M, Schaumburg B, Mueller Z, Parplys A, Jarczak D, Roedl K, et al. High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study. Emerg Microbes Infect. 2021;10(1):1807–18.
van Zeggeren IE, Boelen A, van de Beek D, Heijboer AC, Vlaar APJ, Brouwer MC, et al. Sex steroid hormones are associated with mortality in COVID-19 patients: level of sex hormones in severe COVID-19. Med (Baltim). 2021;100(34):e27072.
Auerbach JM, Khera M. Testosterone’s role in COVID-19. J Sex Med. 2021;18(5):843–8.
Frara S, Loli P, Allora A, Santini C, di Filippo L, Mortini P, et al. COVID-19 and hypopituitarism. Rev Endocr Metab Disord. 2022;23(2):215–31.